Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]Heinz Ludwig, J. C. Schuster, H. Samonigg et al.|Blood|1994Cited by 193
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]Heinz Ludwig, J. C. Schuster, H. Samonigg et al.|Blood|1994Cited by 129
Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.Georg Pfeiler, Michael Gnant, Robert Königsberg et al.|Journal of Clinical Oncology|2010Cited by 15
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancerH. Hausmaninger, Georg Kemmler, Renate Haidinger et al.|European Journal of Cancer|1995Cited by 11
Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.Georg Pfeiler, Michael Gnant, Robert Königsberg et al.|Journal of Clinical Oncology|2011Cited by 4